Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-05 7:08 pm Sale | 2024-08-12 | 13G | Harrow Health, Inc. HROW | Daniel Kaufman | 1,684,424 4.750% | -222,908 (-11.69%) | Filing History |
| 2024-10-08 06:41 am Sale | 2022-12-31 | 13G | Harrow Health, Inc. HROW | Ophir Asset Management Pty Ltd | 768,916 2.800% | -1,136,438 (-59.64%) | Filing History |
| 2024-04-30 07:00 am Sale | 2024-04-26 | 13D | Eton Pharmaceuticals, Inc. ETON | HARROW INC. HROW | 0 0.000% | -1,982,000 (Position Closed) | Filing History |
| 2024-02-13 5:25 pm Purchase | 2023-12-31 | 13G | Harrow Health, Inc. HROW | Daniel Kaufman | 1,907,332 5.430% | 22,300 (+1.18%) | Filing History |
| 2024-02-13 5:06 pm Purchase | 2023-12-29 | 13G | Harrow Health, Inc. HROW | The Vanguard Group | 1,808,552 5.150% | 1,808,552 (New Position) | Filing History |
| 2024-02-09 4:05 pm Purchase | 2023-12-31 | 13G | Harrow Health, Inc. HROW | Opaleye Management Inc. | 3,820,000 10.880% | 45,000 (+1.19%) | Filing History |
| 2024-01-29 3:26 pm Purchase | 2023-12-31 | 13G | Harrow Health, Inc. HROW | BlackRock Inc. BLK | 2,220,538 6.300% | 1,806,673 (+436.54%) | Filing History |
| 2024-01-09 10:16 am Purchase | 2023-12-31 | 13G | Harrow Health, Inc. HROW | Private Capital Management LLC | 3,630,496 10.340% | 3,630,496 (New Position) | Filing History |
| 2023-11-22 7:23 pm Purchase | 2023-11-15 | 13G | Harrow Health, Inc. HROW | Daniel Kaufman | 1,885,032 5.370% | 1,885,032 (New Position) | Filing History |
| 2023-08-18 4:42 pm Purchase | 2023-07-18 | 13D | Harrow Health, Inc. HROW | BAUM MARK L | 3,488,361 9.500% | 3,488,361 (New Position) | Filing History |
| 2023-01-20 4:59 pm Purchase | 2022-12-31 | 13G | Harrow Health, Inc. HROW | Opaleye Management Inc. | 3,775,000 12.820% | 490,000 (+14.92%) | Filing History |
| 2022-02-14 3:22 pm Purchase | 2021-12-31 | 13G | Harrow Health, Inc. HROW | Ophir Asset Management Pty Ltd | 1,905,354 7.080% | 1,905,354 (New Position) | Filing History |
| 2022-02-10 4:32 pm Sale | 2021-12-31 | 13G | Harrow Health, Inc. HROW | RENAISSANCE TECHNOLOGIES LLC | 1,199,112 4.460% | -294,100 (-19.70%) | Filing History |
| 2022-01-28 4:05 pm Sale | 2021-04-12 | 13D | Eton Pharmaceuticals, Inc. ETON | HARROW INC. HROW | 1,982,000 8.100% | -1,518,000 (-43.37%) | Filing History |
| 2022-01-25 9:43 pm Purchase | 2021-12-31 | 13G | Harrow Health, Inc. HROW | Opaleye Management Inc. | 3,285,000 12.200% | 219,584 (+7.16%) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Harrow Health, Inc. HROW | BlackRock Inc. BLK | 413,865 1.600% | -1,118,799 (-73.00%) | Filing History |
| 2021-04-27 5:25 pm Purchase | 2021-04-25 | 13D | IMPRIMIS PHARMACEUTICALS, INC. IMMY | BAUM MARK L | 2,367,072 8.600% | 897,662 (+61.09%) | Filing History |
| 2021-02-12 5:20 pm Purchase | 2020-12-31 | 13G | Harrow Health, Inc. HROW | Opaleye Management Inc. | 3,065,416 11.910% | 3,065,416 (New Position) | Filing History |
| 2021-02-10 11:01 am Purchase | 2020-02-27 | 13G | Harrow Health, Inc. HROW | RENAISSANCE TECHNOLOGIES LLC | 1,493,212 5.800% | 1,493,212 (New Position) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Harrow Health, Inc. HROW | BlackRock Inc. BLK | 1,532,664 6.000% | 1,532,664 (New Position) | Filing History |